Table 1 Baseline characteristics
From: Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
Non-carrier | PMC | SMC | |
|---|---|---|---|
N | 23 | 29 | 7 |
Sex, n (%) | |||
Men | 16 (70%) | 16 (55%) | 5 (71%) |
Women | 7 (30%) | 13 (45%) | 2 (29%) |
Age, years (mean (SD)) | 40.9 (12.4) | 34.6 (7.0) | 49.8 (9.5) |
EYO, years (mean (SD)) | N/A | -13.6 (7.5) | 2.5 (3.9) |
MMSE (median [IQR]) | 30 [29, 30] | 30 [29, 30] | 27 [20, 29] |
CDR Global (median [IQR]) | 0 [0, 0] | 0 [0, 0] | 0.5 [0.5, 1] |
Tau PET follow-up intervala, years (mean, (SD), number with more than one visit) | 2.1 (0.8) n = 9 | 2.4 (1.0) n = 15 | 2.8 (1.9) n = 2 |